Emodin reverses leukemia multidrug resistance by competitive inhibition and downregulation of P-glycoprotein

Development of multidrug resistance (MDR) is a continuous clinical challenge partially due to the overexpression of P-glycoprotein (P-gp) for chronic myelogenous leukemia (CML) patients. Herein, we evaluated the inhibitory potency of emodin, a natural anthraquinone derivative isolated from Rheum pal...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:PLoS One
Autori principali: Min, Hongping, Niu, Miaomiao, Zhang, Weilin, Yan, Jia, Li, Jiachang, Tan, Xiying, Li, Bo, Su, Mengxiang, Di, Bin, Yan, Fang
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2017
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5679605/
https://ncbi.nlm.nih.gov/pubmed/29121121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0187971
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi